NDC11 69794033201
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 69794-0332-01 | 69794-0332 |
| 69794-0332-1 | 69794-0332 |
| 69794-332-01 | 69794-332 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GENGLYCOS | PARIGLASGENE BRECAPARVOVEC-OPNR | Ultragenyx Pharmaceutical Inc. | ef9144f5-10c3-47d9-a7c6-ab5ff11e9bf8 | 2026-08-28 | Warnings, Adverse reactions | 69794-332-01 69794033201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.